Literature DB >> 31149066

IS THERE A RELATIONSHIP BETWEEN PARATHYROID HORMONE AND NEUTROPHIL LYMPHOCYTE RATIO OR PLATELET LYMPHOCYTE RATIO?

A Toraman1, F Aras2, Z Hekimsoy3, S Kursat1.   

Abstract

CONTEXT: Neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) are recent prognostic markers associated with inflammation in many diseases such as chronic kidney disease (CKD), malignancies, myocardial infarction.
OBJECTIVE: In this study, we investigated the relationship between NLR-PLR and parathyroid hormone (PTH) and vitamin D in patients with high PTH levels.
DESIGN: The patients with high PTH levels in Nephrology and Endocrinolgy Outpatient clinics were evaluated retrospectively. SUBJECTS AND METHODS: The medical records of the patients were examined and clinical data, including demographic details, clinical and laboratory findings, treatment and follow-up data were obtained. NLR and PLR were calculated. Serum creatinine, calcium, phosphorus, magnesium, lipid levels, calcium phosphorus product, PTH and vitamin D values were investigated. The relationship between NLR-PLR and laboratory parameters, GFR (MDRD-GFR), PTH and vitamin D were investigated.
RESULTS: 48 male and 253 female patients were enrolled in this study. The mean age was 57.57±13.28. NLR correlated negatively with albumin, hemoglobin, vitamin D, calcium and cholesterol and it positively correlated with creatinine and PTH. Multiple regression analysis showed that main determinants of NLR were PTH, albumin, LDL-cholesterol, hemoglobin and gender.
CONCLUSIONS: In this study NLR and PLR correlated negatively with hemoglobin and cholesterol. Positive correlation between NLR and creatinine could be explained by increased degrees of inflammation associated with more pronounced degrees of renal dysfunction. The impact of PTH on NLR was independent of GFR. In multiple regression model this suggests that PTH could be a pro-inflammatory parameter independent of the degree of renal dysfunction.

Entities:  

Keywords:  Hyperparathyroidism; chronic kidney disease; inflammation; neutrophil lymphocyte ratio; platelet lymphocyte ratio

Year:  2019        PMID: 31149066      PMCID: PMC6535317          DOI: 10.4183/aeb.2019.96

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  20 in total

Review 1.  Epidemiology of cardiovascular risk factors in chronic renal disease.

Authors:  J Coresh; J C Longenecker; E R Miller; H J Young; M J Klag
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

2.  Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients.

Authors:  Brendon L Neuen; Nicole Leather; Alice M Greenwood; Ronny Gunnarsson; Yeoungjee Cho; Murty L Mantha
Journal:  Ren Fail       Date:  2015-11-05       Impact factor: 2.606

3.  Inflammatory biomarkers in patients with asymptomatic primary hyperparathyroidism.

Authors:  Ahmed Alsayed Emam; Sabela Gomaa Mousa; Karema Yousif Ahmed; Adel A Al-Azab
Journal:  Med Princ Pract       Date:  2011-12-16       Impact factor: 1.927

4.  Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients.

Authors:  Kultigin Turkmen; Fatih Mehmet Erdur; Fatih Ozcicek; Adalet Ozcicek; Emin Murat Akbas; Aysu Ozbicer; Levent Demirtas; Suleyman Turk; H Zeki Tonbul
Journal:  Hemodial Int       Date:  2013-03-24       Impact factor: 1.812

Review 5.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.

Authors:  Weerapan Khovidhunkit; Min-Sun Kim; Riaz A Memon; Judy K Shigenaga; Arthur H Moser; Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2004-04-21       Impact factor: 5.922

6.  Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism.

Authors:  Elena Chertok-Shacham; Avraham Ishay; Idit Lavi; Rafael Luboshitzky
Journal:  Med Sci Monit       Date:  2008-12

7.  Relationship Between the Neutrophil to Lymphocyte Ratio and Parathyroid Adenoma Size in Patients With Primary Hyperparathyroidism.

Authors:  Sezgin Zeren; Faik Yaylak; Isa Ozbay; Zulfu Bayhan
Journal:  Int Surg       Date:  2015-07

8.  Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study.

Authors:  A J van Ballegooijen; I Reinders; M Visser; J M Dekker; G Nijpels; C D A Stehouwer; S Pilz; I A Brouwer
Journal:  J Clin Endocrinol Metab       Date:  2013-02-13       Impact factor: 5.958

9.  Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease.

Authors:  Ismail Kocyigit; Eray Eroglu; Aydin Unal; Murat Hayri Sipahioglu; Bulent Tokgoz; Oktay Oymak; Cengiz Utas
Journal:  J Nephrol       Date:  2012-05-08       Impact factor: 3.902

10.  A prospective observational study of all-cause mortality in relation to serum 25-OH vitamin D3 and parathyroid hormone levels in patients with type 2 diabetes.

Authors:  Pär Jennersjö; Hans Guldbrand; Stefan Björne; Toste Länne; Mats Fredrikson; Torbjörn Lindström; Magnus Wijkman; Carl Johan Östgren; Fredrik H Nystrom
Journal:  Diabetol Metab Syndr       Date:  2015-06-12       Impact factor: 3.320

View more
  2 in total

1.  Low serum parathyroid hormone is a risk factor for peritonitis episodes in incident peritoneal dialysis patients: a retrospective study.

Authors:  Yuqi Yang; Jingjing Da; Yi Jiang; Jing Yuan; Yan Zha
Journal:  BMC Nephrol       Date:  2021-01-29       Impact factor: 2.388

Review 2.  Serum Inflammation-based Scores in Endocrine Tumors.

Authors:  Pedro Marques; Friso de Vries; Olaf M Dekkers; Márta Korbonits; Nienke R Biermasz; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.